男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Negotiators work to bring down nation's prescriptions

Public paying dramatically less for therapeutic drugs thanks to bulk-buy scheme

By WANG XIAOYU | China Daily | Updated: 2025-02-06 08:47
Share
Share - WeChat
A worker checks capsules on a production line in Liuyang, Hunan province, in June. CHEN SIHAN/XINHUA

Du Wentao, chairman of Yichang Humanwell Pharmaceutical, said during an interview with state broadcaster China Central Television that it has spent five years and over 70 million yuan in researching the drug.

"So far, our drugs have only been introduced to less than 20 percent of relevant hospitals and many parents have to travel far to larger hospitals to obtain the drug," he said. "Getting on the list means that grassroots coverage for the drug will be improved and more child patients can access effective treatment."

Wu Jing, deputy dean of Tianjin University's School of Pharmaceutical Science and Technology, said, "The speedy action related to boosting access to the drug has demonstrated the government's attention to the rare disease patient community."

Even though the market price of domestic Clobazam per tablet is only 3 yuan, Wu said that the medicine is usually delivered along with other drugs and the total costs constitute a heavy burden on some families.

"The price reduction could range from a few percent to over 90 percent because the principle is not purely chasing after steep cuts, but a pursuit of the most reasonable price," Wu said. "All negotiated prices will be tested against economic barometers that evaluate clinical value."

Huang, the official from the National Healthcare Security Administration, said that during price negotiations in late October, a total of 28 drugs failed to secure a deal. The reason was that their anticipated prices had exceeded the bottom-line price by a giant margin, and some drugmakers were unwilling to reduce their prices to a level lower than the international average.

Authorities were looking for the lowest price compared to the United States, the United Kingdom, Japan and other developed countries, which have a much higher GDP per capita compared to China. It is reasonable to ask for a lower price than these markets considering China's large population, Huang said.

|<< Previous 1 2 3 4 5 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 林周县| 若尔盖县| 延长县| 崇阳县| 贡山| 内江市| 清徐县| 宜宾县| 新民市| 年辖:市辖区| 宁阳县| 沁水县| 上杭县| 青海省| 镇远县| 达孜县| 静宁县| 大余县| 浮梁县| 自贡市| 苗栗市| 敖汉旗| 绍兴县| 肥城市| 固镇县| 平武县| 兴山县| 大冶市| 石门县| 惠来县| 大英县| 黑河市| 靖州| 泰顺县| 乌拉特后旗| 康定县| 湘潭县| 长丰县| 正宁县| 乌兰察布市| 应用必备|